Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
16.16
-0.56 (-3.35%)
At close: Nov 16, 2026

Bio-Thera Solutions Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-441.01-331.94-510.3-394.53-480.481.94
Depreciation & Amortization
102.96102.9689.3985.2483.8472.94
Other Amortization
2.292.290.650.11--
Loss (Gain) From Sale of Assets
1.721.720.01-0.03-0-
Asset Writedown & Restructuring Costs
0.820.820.5-6.920.070.02
Loss (Gain) From Sale of Investments
-1.38-1.38-4.68-3.87-25.03-27.6
Provision & Write-off of Bad Debts
0.060.060.230.19-0.710.9
Other Operating Activities
234.3620.3720.8611.780.630.69
Change in Accounts Receivable
-166.03-166.0344.85-99.327.121.88
Change in Inventory
-59.42-59.42-21.87-69.33-71.8-44.47
Change in Accounts Payable
348.43348.43299.3741.1453.48129.99
Change in Other Net Operating Assets
--25.35-25.35--
Operating Cash Flow
22.81-82.11-55.65-460.87-412.82236.27
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-278.89-121.74-126.85-262.14-258.82-77.89
Sale of Property, Plant & Equipment
0.170.18000.030
Investment in Securities
9090240288-28340
Other Investing Activities
0.7822.875.4911.7140.9939.65
Investing Cash Flow
-187.93-8.69118.6437.57-245.8301.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-360.27378.93441.85330
Total Debt Issued
624.76360.27378.93441.85330
Long-Term Debt Repaid
--298.58-277.73-34.97-32.99-2.91
Lease Payments
-0.06-0.06-3.24-3.77-2.99-2.91
Total Debt Repaid
-303.97-298.58-277.73-34.97-32.99-2.91
Net Debt Issued (Repaid)
320.7961.68101.2406.88-29.9927.09
Common Dividends Paid
-21.03-20.39-20.6-9.32-0.16-0.55
Other Financing Activities
--6.69-2.4--
Financing Cash Flow
299.7541.2987.28395.16-30.1526.54

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.8-0.580.610.570.77-0.8
Net Cash Flow
130.83-50.1150.88-27.58-688563.77

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-256.08-203.86-182.5-723.01-671.64158.38
Free Cash Flow Growth
------
Free Cash Flow Margin
-24.41%-21.80%-24.56%-102.58%-147.57%18.93%
Free Cash Flow Per Share
-0.61-0.49-0.44-1.74-1.620.39
Levered Free Cash Flow
-380.93-298.07-108.15-591.18-510.6434.74
Unlevered Free Cash Flow
-367.87-285.53-95.31-584.69-510.635.23
Free Cash Flow After Leases
-256.14-203.91-185.75-726.77-674.63155.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
14.618.5219.94-23.92-34.41-24.37
Change in Working Capital
122.98122.98347.69-152.848.78107.4